-----BEGIN PRIVACY-ENHANCED MESSAGE----- Proc-Type: 2001,MIC-CLEAR Originator-Name: webmaster@www.sec.gov Originator-Key-Asymmetric: MFgwCgYEVQgBAQICAf8DSgAwRwJAW2sNKK9AVtBzYZmr6aGjlWyK3XmZv3dTINen TWSM7vrzLADbmYQaionwg5sDW3P6oaM5D3tdezXMm7z1T+B+twIDAQAB MIC-Info: RSA-MD5,RSA, EeBq2d1u8dKAhQ5O2VBpwP0fgtr1Mu9/d8MiQrIwftjJswUrhPa+ueoRh0A27vxl Q1h7dDYWfJtNS9hOudJJJg== 0000000000-05-060978.txt : 20060926 0000000000-05-060978.hdr.sgml : 20060926 20051206153109 ACCESSION NUMBER: 0000000000-05-060978 CONFORMED SUBMISSION TYPE: UPLOAD PUBLIC DOCUMENT COUNT: 1 FILED AS OF DATE: 20051206 FILED FOR: COMPANY DATA: COMPANY CONFORMED NAME: HUMAN BIOSYSTEMS INC CENTRAL INDEX KEY: 0001070181 STANDARD INDUSTRIAL CLASSIFICATION: SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH [8731] IRS NUMBER: 770481056 STATE OF INCORPORATION: CA FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: UPLOAD BUSINESS ADDRESS: STREET 1: 1127 HARKER AVE CITY: PALO ALTO STATE: CA ZIP: 94301 BUSINESS PHONE: 6503230943 MAIL ADDRESS: STREET 1: 1127 JARKER AVENUE CITY: PALO ALTO STATE: CA ZIP: 94301 PUBLIC REFERENCE ACCESSION NUMBER: 0001091818-05-000333 LETTER 1 filename1.txt Via Facsimile and U.S. Mail Mail Stop 6010 December 1, 2005 Harry Masuda Chief Executive Officer Human BioSystems 1127 Harker Avenue Palo Alto, CA 94301 Re: Human BioSystems Registration Statement on Form SB-2, Filed October 13, 2005, amended November 22, 2005 Registration No. 333-128991 Dear Mr. Masua: This is to advise you that we have undertaken a limited review of the above referenced registration statement and have the following comments. We and our Chief Executive Officer are the subject of SEC and Justice Department proceedings for securities fraud. 1. We note our prior comment 1 and your response. You should expand the disclosure to explain why you believe, "the issues involved in this matter were resolved over two years ago to the full satisfaction of all investors." Disclose how much was repaid and to whom. 2. Please explain why you believe the deferred prosecution agreement between the government and Mr. Masuda should lead to a dismissal of all charges against him. Absent a well-founded and factually supported belief that this will happen, you should delete this prediction. Liquidity and Capital Resources 3. We note our prior Comment 4 and your response and reissue the comment. As to the Ben David transaction, please state how many shares Mr. Ben David sold or transferred. * * * As appropriate, please amend your registration statement in response to these comments. You may wish to provide us with marked copies of the amendment to expedite our review. Please furnish a cover letter with your amendment that keys your responses to our comments and provides any requested supplemental information. Detailed cover letters greatly facilitate our review. Please understand that we may have additional comments after reviewing your amendment and responses to our comments. Please contact Michael Reedich at (202) 551-3612 or to me at (202) 551-3710. Sincerely, Jeffrey Riedler Assistant Director cc: Cathryn Gawne Silicon Valley Law Group 25 Metro Drive, Suite 600 San Jose, CA 95110 1 -----END PRIVACY-ENHANCED MESSAGE-----